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Introduction
Apoptosis is a central physiological cell-death process that occurs
during the entire lifetime of metazoans and is executed by proteases
of the caspase family. In response to intrinsic or extrinsic death
signals, most human cells induce apoptosis via the mitochondrial
(type II) pathway. Type-II apoptosis involves Bax-Bak-dependent
mitochondrial-outer-membrane permeabilisation (MOMP),
followed by co-release of mitochondrial-intermembrane-space
proteins [cytochrome c, Smac (Diablo), Omi (HtrA2)] and
concomitant mitochondrial depolarisation (Goldstein et al., 2000;
Munoz-Pinedo et al., 2006; Rehm et al., 2003). Subsequent
activation of caspase-9 and executioner caspase-3 leads to
proteolysis of hundreds of substrates, nuclear condensation and
fragmentation, and the dismantling of cells into apoptotic bodies.
Once initiated, MOMP and effector-caspase activation proceed
with rapid kinetics, reaching completion within minutes (Goldstein
et al., 2000; Rehm et al., 2002). By contrast, the lag time between
exposure to intrinsic or extrinsic death stimuli and MOMP or
apoptosis execution is strongly stimulus- and dose-dependent, and
is highly variable between cells from clonal populations (Rehm et
al., 2002; Rehm et al., 2009).
Type-II apoptosis that is initiated via death ligands such as
TRAIL requires the activation of caspase-8 upstream of
mitochondrial engagement. TRAIL binds to its cognate death
receptors (DR) 4 and 5, which, following receptor oligomerisation,
recruit the cytosolic adaptor protein FADD and procaspase-8
(Bodmer et al., 2000; Sprick et al., 2000). Procaspase-8 is activated,
and autocatalytically processed mature caspase-8 can be released
into the cytosol (Chang et al., 2003; Donepudi et al., 2003; Martin
et al., 1998), where it cleaves its prime proapoptotic substrate Bid.
Truncated Bid (tBid) then accumulates at the mitochondria to
induce MOMP via the formation of Bax-Bak pores (Li et al.,
1998).
Förster resonance energy transfer (FRET) probes can be
employed to measure intracellular protease activities that cleave
peptides linking donor and acceptor fluorophores. In contrast to
synthetic, proteolytically dequenchable fluorigenic substrates,
ratiometric FRET readouts are highly sensitive because they are
based on initial non-zero fluorescence signals and thus are not
impaired by detection limits to low emission intensities. We and
others developed CFP-YFP FRET probes containing an optimal
caspase-8 recognition site (IETD) to measure caspase-8 signalling
kinetics during TRAIL-induced initiation of apoptosis (Albeck et
al., 2008; Hellwig et al., 2008). These studies highlighted high
cell-to-cell variability and dose dependency of caspase-8 activation
and activity upstream of mitochondrial engagement (Albeck et al.,
2008; Hellwig et al., 2008). We could furthermore show that this
variability is translated into a strict response of MOMP and
apoptosis execution once a conserved amount of cleaved substrate
has accumulated (Hellwig et al., 2008).
However, it remained unclear whether the cleavage of recombinant
IETD substrates indeed reflects cleavage of physiological substrates
of caspase-8, such as Bid. Although caspase-8 activity and large
quantities of IETD-substrate cleavage can be detected several minutes
and hours prior to MOMP (Albeck et al., 2008; Hellwig et al., 2008),
biochemical studies suggested that very low tBid concentrations are
already sufficient to induce MOMP (Li et al., 1998; Luo et al., 1998;
Martinez-Caballero et al., 2009). Here, we therefore investigated the
temporal relationship of caspase-8 activation and Bid cleavage in
individual HeLa cervical cancer cells during TRAIL- and TNF-
induced apoptosis initiation by employing combinations of
fluorescent reporter constructs and advanced time-lapse imaging.
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Summary
In the present study, we quantitatively analysed the interface between apoptosis initiation and execution by determining caspase-8
activation, Bid cleavage and mitochondrial engagement (onset of mitochondrial depolarisation) in individual HeLa cervical cancer
cells following exposure to tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL). Employing resonance-energy-transfer
probes containing either the caspase-8 recognition site IETD or full-length Bid, we observed a significant delay between the times of
caspase-8 activation and Bid cleavage, suggesting the existence of control steps separating these two processes. Subsequent analyses
suggested that the divergence of caspase-8 activation and Bid cleavage are critically controlled by kinase signalling: inhibiting protein
kinase CK2 by using 5,6-dichloro-l-(-D-ribofuranosyl-1)-benzimidazole (DRB) or by overexpression of a dominant-negative CK2
catalytic subunit largely eliminated the lag time between caspase-8 activation and Bid cleavage. We conclude that caspase-8 activation
and Bid cleavage are temporally uncoupled events, providing transient tolerance to caspase-8 activities.
Key words: Apoptosis, Tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL), Protein kinase CK2, Bid, Caspase-8, Förster resonance
energy transfer (FRET)
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Results and Discussion
Differential cleavage of IETD and Bid FRET substrates
during TRAIL-induced apoptosis
To examine whether IETD-based probes reliably reflect the
cleavage kinetics of Bid in individual cells, we compared FRET
probes containing either an IETD peptide or full-length Bid
(Hellwig et al., 2008; Onuki et al., 2002). We expressed both
probes in HeLa cells and induced death-receptor-mediated apoptosis
by the addition of TRAIL. Cycloheximide (CHX) was added in
parallel to investigate the apoptosis signalling branch without
strong interference from NFB-mediated survival signalling
(Falschlehner et al., 2007). CHX did not cause any detectable
amount of cell death following 24 hours of treatment (not shown).
HeLa cells require the mitochondrial pathway for the activation of
effector caspases and apoptosis execution (Albeck et al., 2008;
Engels et al., 2000; Hellwig et al., 2008), and are a widely used
experimental cell system for the real-time photonic analysis of
intracellular apoptosis signalling. For both FRET probes we
optimised the acquisition procedure to minimise potential
phototoxic damage while still achieving high signal-to-noise ratios.
Confirming previous studies (Albeck et al., 2008; Hellwig et al.,
2008), caspase-8 activation was detected before apoptotic
mitochondrial engagement when using the IETD FRET probe (Fig.
1A), whereas, subsequent to MOMP, the activation of effector
caspases contributed to a significant increase in the substrate
cleavage rates (Fig. 1A). By contrast, the onset of Bid FRET
disruption was closely correlated with mitochondrial engagement
and then followed post-MOMP kinetics similar to the IETD FRET
probe (Fig. 1B). Experimental baselines lacked slopes, ensuring
that the measured signals were not a consequence of acceptor
photobleaching/donor un-quenching during data acquisition (Fig.
1A,B). When defining the detection limit for probe cleavage as an
irreversible deviation from the baseline noise, we achieved a
sensitivity of 2.5% and 3.2% substrate cleavage for the IETD
FRET and Bid FRET probes, respectively. Taken together, these
results therefore suggest that Bid cleavage might not be initiated
upon caspase-8 activation but instead might be subject to additional
control steps.
The lag time between caspase-8 and Bid activation is
sensitive to inhibition of protein kinase CK2
Previous in vitro and cell-population-based studies suggested that
protein kinase CK2 might play an additional regulatory role at the
interface between extrinsic apoptosis initiation and mitochondrial
engagement (Desagher et al., 2001; Li et al., 2002; Shin et al.,
2005). Human protein kinase CK2 represents two constitutively
active serine/threonine kinase isoforms of broad substrate
specificity, phosphorylating hundreds of known targets both in the
cytosol and the nucleus (Litchfield, 2003; Sarno and Pinna, 2008).
Abnormally elevated CK2 activities might be tumorigenic and
indeed have been repeatedly detected in various cancers (Duncan
and Litchfield, 2008).
In subsequent experiments, we therefore investigated whether
CK2 activity contributes to the differential cleavage of IETD
substrates and Bid. To investigate caspase-8 and Bid activation in
parallel within individual cells, we combined the expression of the
IETD FRET probe with a spectrally compatible red fluorescent
Bid-Cherry fusion protein. As shown before for other fluorescently
labelled Bid probes (Nechushtan et al., 2001), Cherry fluorescence
redistributed into a punctate pattern during apoptosis, indicating
tBid-Cherry accumulation at mitochondria (Fig. 2A). Likewise,
the Bid-Cherry fusion protein was able to re-sensitize Bid-depleted
HeLa cells to apoptosis induction by TRAIL and was cleaved in
parallel with native Bid in immunoblotting experiments
(supplementary material Fig. S1A,B).
To achieve rapid and specific CK2 inhibition in all cells
observed, we employed a short (2 hour) pretreatment with the
specific CK2 inhibitor 5,6-dichloro-l-(-D-ribofuranosyl-1)-
benzimidazole (DRB) (Meggio et al., 1990; Zandomeni and
Weinmann, 1984). Time-lapse imaging of control HeLa cells, as
expected, showed that the IETD FRET probe was cleaved before
tBid-Cherry translocation could be detected (Fig. 2B). By contrast,
in DRB pretreated cells, the delay between the onset of IETD
FRET cleavage and Bid activation was essentially abrogated (Fig.
2C,D). These results suggest that Bid processing is temporally
uncoupled from caspase-8 activation in a DRB-sensitive manner.
In additional control experiments, prolonged treatment of HeLa
cells with 50 M DRB did not result in any detectable apoptosis
execution during the time course of the experiments (supplementary
material Fig. S2A). Except for a mild reduction in cFlipL and
slightly increased DR5 levels, the abundance of key proteins
involved in death-inducing signalling complex (DISC) formation,
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Fig. 1. Comparison of IETD-FRET-substrate and Bid-FRET-substrate
cleavage. (A)HeLa cells expressing a CFP-IETD-YFP FRET probe were
loaded with 30 nM TMRM and treated with TRAIL (10 ng/ml) and CHX
(1g/ml). CFP:YFP traces of three representative cells are shown with
mitochondrial engagement (onset of mitochondrial depolarisation) set to time
zero. Onset of IETD-substrate cleavage by caspase-8 precedes mitochondrial
engagement during apoptosis (T). Similar results were recorded for n10
cells. Baselines control for the absence of photobleaching-induced signal
changes. Baseline noise (mean ± s.d.) is indicated in grey. (B)HeLa cells
expressing a YFP-Bid-CFP FRET probe were treated and analysed as in A.
CFP:YFP traces of three representative cells are shown. Similar results were
recorded for all cells analysed (n22).
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mitochondrial permeabilisation or apoptosis execution did not
noticeably change in response to CK2 inhibition by DRB
(supplementary material Fig. S2B-D). This suggests that the
abrogation of the lag time between caspase-8 and Bid activation
was not affected by perturbing the role of CK2 in transcriptional
regulation (Litchfield, 2003) but is more likely a rather immediate
response due to altered phosphorylation patterns of other CK2
substrates.
To investigate whether impaired CK2 activity affected kinetics
other than the lag time between caspase-8 activation and Bid
cleavage, we investigated parameters that can be obtained from
individual cells by using the IETD FRET probe (Fig. 3A) (Hellwig
et al., 2008): (i) the time from stimulus addition to caspase-8
activation, entailing the processes from death ligands binding to
their receptors until caspase-8 activation; (ii) the time from caspase-
8 activation until mitochondrial engagement; (iii) the amount of
cleaved substrate at the time of mitochondrial engagement, which
can serve to measure the decision threshold for subsequent
apoptosis execution; and (iv) the short post-MOMP delay after
which cleavage rates of the IETD substrate strongly increase owing
to activation of effector caspase-3 and -7. We quantified these
parameters in the absence or presence of CK2 inhibition (Fig.
3B-E). In addition to the pharmacological inhibition of CK2 by
DRB, we also overexpressed a kinase-inactive mutant of the CK2
subunit (CK2 K68M), which competitively interferes with the
functioning of endogenous CK2 (Vilk et al., 1999).
The lag time between TRAIL addition and onset of cleavage of
the IETD FRET probe did not differ between the three groups (Fig.
3B), suggesting that the upstream signalling from ligand binding
to caspase-8 activation was not affected by CK2 inhibition. As
expected, we again noticed that the lag time between caspase-8
activation and mitochondrial engagement was completely abrogated
upon DRB pretreatment, i.e. the onset of IETD-substrate cleavage
coincided with mitochondrial engagement (Fig. 3C).
Overexpression of CK2 K68M similarly reduced the lag time
between caspase-8 activation and mitochondrial depolarisation
(Fig. 3C). The time of mitochondrial engagement coincided with
cleavage of approximately 10% of the IETD FRET substrate in
control HeLa cells, whereas DRB treatment or CK2-K68M
overexpression abolished or reduced the amount of substrate
cleaved at the time of mitochondrial engagement (Fig. 3D).
Efficient effector-caspase activation, as indicated by a significant
increase in the FRET-substrate cleavage rate, was detected within
approximately 2-4 minutes following mitochondrial engagement,
independent of whether CK2 was inhibited or not (Fig. 3E). Similar
results were obtained in MCF-7 breast cancer cells treated with
TRAIL and CHX in the presence or absence of DRB (n9 or 15
cells analysed, respectively; not shown), or when inducing apoptosis
in HeLa cells with TNF and CHX (Fig. 3F). Furthermore,
additional control experiments indicated that CK2 inhibition did
not affect the activity of caspase-8 (supplementary material Fig.
S2E). Overexpression of exogenous CK2 did not significantly
alter the signalling kinetics (seven cells from n3 experiments; not
shown), suggesting that the activity of the native holoenzyme is
not limited by availability of the -subunit in HeLa cells. Taken
together, these results indicate that CK2 activity does not affect
either the time required for caspase-8 activation or the signalling
kinetics subsequent to mitochondrial engagement. Instead, these
data further suggest that CK2 activity is required to provide cells
with transient tolerance to caspase-8 activity.
Our study demonstrated that, within living cells, caspase-8
activation and the proteolytic activation of caspase-8 substrate Bid
are temporally separated events. In HeLa cells, the activity of
protein kinase CK2 provided transient tolerance to caspase-8
activity by delaying Bid cleavage, a process that otherwise would
induce MOMP immediately. Readings obtained from the use of
recombinant IETD substrates therefore require careful interpretation
(Albeck et al., 2008; Hellwig et al., 2008; Spencer et al., 2009).
Likewise, system models that were designed to calculate a fast
pore-formation process during MOMP so far assumed that the
production of tBid could be deduced immediately from IETDase
activities. Such models would benefit from including the
biochemistry of an additional control step at the interface of
caspase-8 and Bid activation to more authentically represent the
biology of apoptotic signal transduction.
Short exposure to the CK2 inhibitor DRB was sufficient to
eliminate the lag time between caspase-8 activation and Bid
cleavage; this result is most likely caused by modulation of the
phosphorylation status of CK2 substrates rather than by influencing
CK2-dependent transcriptional processes. CK2 substrates whose
anti- or proapoptotic potential was suggested to be modulated by
1403Caspase-8 activation and Bid cleavage
Fig. 2. CK2-dependent separation of caspase-8 activation and Bid
cleavage. (A)Confocal scans of HeLa cells expressing Bid-Cherry, loaded
with 50 nM MitoTracker Green. Cherry fluorescence redistributed to
mitochondria following exposure to TRAIL (100 ng/ml) and CHX (1g/ml)
for 6 hours. Scale bar: 10m. (B)Caspase-8 activation precedes mitochondrial
tBid accumulation during TRAIL-induced apoptosis. HeLa cells expressing
the IETD FRET probe and Bid-Cherry were treated with 100 ng/ml TRAIL
and CHX. CFP:YFP traces of three representative cells are shown in relation
to the onset of mitochondrial tBid accumulation. (C)CK2 inhibition abrogates
the temporal separation between caspase-8 activation and mitochondrial tBid
accumulation. Cells expressing the IETD FRET probe and Bid-Cherry were
pretreated for 2 hours with 50M DRB and then treated with 100 ng/ml
TRAIL and 1 g/ml CHX. CFP:YFP traces of three representative cells are
shown in relation to the onset of mitochondrial tBid accumulation.
(D)Quantification of all cells measured (n12 cells/group; data are means ±
s.e.m.). *Significant (P<0.01); Student’s t-test.
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phosphorylation include apoptosis repressor with caspase
recruitment domain (ARC), caspase-2 and, probably most centrally,
Bid itself (Desagher et al., 2001; Li et al., 2002; Shin et al., 2005).
It was recently shown that the threonine within the caspase-8
cleavage site of Bid is a CK2 target site (Olsen et al., 2006),
potentially explaining previous in vitro data that demonstrated
reduced cleavage rates of Bid peptides that were phosphorylated at
this position (Degli Esposti et al., 2003).
Besides CK2, other serine/threonine kinases such as CK1,
mitogen-activated protein kinases and ataxia telangiectasia-mutated
kinase might modify the functionality of Bid in cell death and
survival signalling (Desagher et al., 2001; Holmstrom et al., 2000;
Kamer et al., 2005; Vogel et al., 2006). Furthermore, several
proposed TRAIL combination therapies build on the potential of
TRAIL to synergize with clinically employed chemotherapeutic
drugs. Among these are multiple kinase inhibitors, such as sorafenib
and gefitinib (Johnstone et al., 2008). Unlike DRB and some of its
derivatives, many of these inhibitors have been shown to be of
rather modest target selectivity (Karaman et al., 2008; Meggio et
al., 1990; Zandomeni and Weinmann, 1984). It is therefore
conceivable that synergies observed in TRAIL co-treatments could
in part be mediated by impaired CK2 activity or Bid
phosphorylation.
It is currently unknown whether de-phosphorylation of Bid by
protein phosphatases is required for apoptosis to proceed or whether
uncatalysed hydrolysis of the phospho-group suffices. We identified
that, in living cells, minimal quantities of tBid (estimated from the
baseline noise of our FRET measurements as less than
approximately 3% of the total Bid pool) are sufficient to trigger
MOMP, a finding that agrees with in vitro biochemical and
mitochondrial patch-clamping studies that found that tBid
concentrations in the picomolar to low-nanomolar range are
sufficient to permeabilise mitochondria (Li et al., 1998; Luo et al.,
1998; Martinez-Caballero et al., 2009). An enzymatically catalysed
process amassing significant amounts of de-phosphorylated Bid
therefore might not be required during caspase-8-mediated
apoptosis. However, glutamate-induced excitotoxic apoptosis and
cell death by anoikis were shown to be mediated at least in part by
translocation of large amounts of full-length Bid, which is far less
efficient in inducing MOMP, to mitochondria (Li et al., 1998; Luo
et al., 1998; Valentijn and Gilmore, 2004; Ward et al., 2006). Of
note, PACS-2, a Bid-recruiting protein that functions also in
controlling the formation of lipid-synthesizing centres in ER-
and/or mitochondria-associated membranes, selectively recruits
only non-phosphorylated Bid to the mitochondrial outer membrane
(Simmen et al., 2005).
1404 Journal of Cell Science 123 (9)
Fig. 3. Consequences of impaired CK2 activity on the kinetics of apoptosis
signalling. (A)Parameters that are quantifiable for individual cells during
TRAIL-induced apoptosis initiation by employing the IETD FRET probe. The
schematic diagram shows cleavage of the IETD FRET probe as an increase in
the CFP:YFP emission ratio (black). The following parameters were
determined for each experimentally analysed cell: (i) the lag time between
stimulus addition and caspase-8/-10 activation; (ii) the lag time between
caspase-8/-10 activation and mitochondrial engagement (drop in TMRM
fluorescence; grey); (iii) the percentage of cleaved substrate at the time of
mitochondrial engagement; (iv) the time from mitochondrial engagement to
the activation of effector caspases. (B-D)Consequences of CK2 inhibition on
TRAIL-mediated apoptosis initiation. Quantification and statistical
comparison of all cells measured in either the absence or presence of CK2
inhibition. All cells were treated with TRAIL (100 ng/ml) and CHX (1g/ml)
after being pre-incubated for 2 hours with vehicle (control) or 50M DRB.
HeLa cells expressing the enzymatically inactive CK2 subunit (CK2
K68M) were transfected at least 24 hours before the addition of TRAIL and
CHX. (B)CK2 inhibition does not delay TRAIL-induced caspase-8 activation.
The time from stimulus addition to caspase-8/-10 activation was quantified for
all cells measured (n9-29 cells/group; data are shown as means ± s.e.m.). n.s.,
not significant (Student’s t-test). (C)CK2 inhibition diminishes the delay from
caspase-8 activation until mitochondrial engagement. The time from caspase-
8/-10 activation to mitochondrial engagement was analysed for all cells
measured (n9-29 cells/group; data are means ± s.e.m.). *Significant (P<0.01;
Student’s t-test). (D)The amount of cleaved IETD FRET substrate at the time
of mitochondrial engagement was analysed for all cells measured (n9-29
cells; data are shown as median ± quartiles). *Significant in comparison to
control group (P<0.02; Bonferroni-corrected Mann-Whitney U-tests).
Diamonds indicate statistical outliers. (E)The lag time between mitochondrial
engagement and increased cleavage rates of the IETD FRET substrate owing
to effector-caspase activation was analysed for all cells measured (n9-29
cells; data are shown as mean + s.d.). n.s., not significant (one-way ANOVA
and subsequent Tukey’s test). (F)HeLa cells were treated with 100 ng/ml
TNF and 1g/ml CHX, either in the absence or presence of 50M DRB
(n15 and 16 cells/group), and analysed as above. Data are means ± s.e.m. or
median ± quartiles. n.s., not significant; *significant (P<0.01) (Student’s t-test
or Mann-Whitney U-test). Circles indicate statistical outliers.
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Ultimately, the interface between caspase-8 activation and tBid
production (and, by extension, the decision to undergo apoptosis
or not) might be of significant physiological importance, because
caspase-8 activities can be functionally separated from cell-death
signalling. This has been demonstrated during macrophage and T-
cell activation and differentiation, and during skin healing (Alam
et al., 1999; Beisner et al., 2003; Kang et al., 2004; Kennedy et al.,
1999; Lee et al., 2009; Rebe et al., 2007). More generally, it might
provide cells with a safeguard mechanism for additional control
steps or to reverse apoptosis initiation upon accidental caspase-8
activation.
Materials and Methods
Materials
Mineral oil and CHX were from Sigma (Tallaght, Ireland). TRAIL was from Leinco
Technologies (St Louis, MO). Tetramethyl-rhodamine-methylester (TMRM) was
from MobiTec (Göttingen, Germany). DRB was from Calbiochem (San Diego, CA).
MitoTracker Green was from Invitrogen (Karlsruhe, Germany). TNF was from
Peprotech (London, UK).
Molecular cloning
For the generation of pBid-mCherry-N1, the coding sequence of Bid was PCR
amplified from human cDNA and cloned in frame into the BglII-EcoRI sites of
pEGFP-N1 (Clontech). To generate pBid-mCherry-N1, the mCherry gene was PCR
amplified from pmCherry-C1 and sub-cloned in frame to BamHI-NotI sites of pBid-
EGFP-N1 following removal of EGFP by restriction. The verity of the constructs
was confirmed by sequencing. Plasmids for the expression of the IETD FRET probe,
the YFP-Bid-CFP FRET probe, CK2 and CK2 K68M were described previously
(Hellwig et al., 2008; Onuki et al., 2002; Vilk et al., 1999).
Cell culture
Cells were cultured in RPMI 1640 medium supplemented with penicillin (100
U/ml), streptomycin (100 g/ml) and 10% fetal calf serum at 37°C and 5% CO2.
Cell transfection was carried out using Metafectene (Biontex Laboratories, Munich,
Germany) according to the manufacturer’s instructions.
Western blotting
Whole-cell extracts, SDS gel electrophoresis and blotting were conducted as described
before (Hellwig et al., 2008). Antibodies used are listed in the figure legend of
supplementary material Fig. S2.
Fluorescence microscopy and data analysis
For time-lapse imaging, cells were grown on 22-mm glass-bottom dishes (Willco
BV, Amsterdam, The Netherlands). Cells were equilibrated with 30 nM TMRM in
medium buffered with N-2-hydroxyl piperazine-N-2-ethane sulfonic acid (HEPES,
10 mM; pH 7.4) and covered with mineral oil. Dishes were placed in a heated (37°C)
incubation chamber that was mounted on the microscope stage and cells were treated
with 100 ng/ml TRAIL or TNF in the presence of 1 g/ml CHX. Fluorescence was
observed using an Axiovert 200 M inverted microscope (Carl Zeiss, Jena, Germany)
or with an LSM5Live confocal microscope (Carl Zeiss, Jena, Germany) equipped
with a 40 NA 1.3 oil-immersion objective, using optimised mirrors and filter sets
(Semrock, Rochester, NY) for the individual fluorescence channels. The Axiovert
200 M was equipped with a cooled EM CCD camera (Andor Ixon BV 887-DCS;
Andor Technologies, Belfast, UK). The cellular TMRM fluorescence intensity was
determined after background subtraction. FRET disruption in the IETD or Bid FRET
probes was detected at the single-cell level as CFP:YFP emission ratios as described
previously (Rehm et al., 2002). Images were processed using MetaMorph 7.1r1
software (Molecular Devices, Wokingham, UK). Irreversible deviation of the signal
from the baseline was considered as the onset of FRET disruption. Bid-Cherry
activation was detected by an increase in the standard deviation of cellular pixel
intensities that resulted from the accumulation of Cherry fluorescence at the
mitochondria (Ward et al., 2006). To verify colocalisation of translocated Bid-Cherry
and mitochondria, MitoTracker Green (Invitrogen) was used to stain mitochondria.
Cells were imaged using an LSM710 confocal microscope (Carl Zeiss, Jena,
Germany).
Statistics
Student’s t-tests were employed for normal-distributed data, otherwise Mann-Whitney
U tests were used. P-values below 0.05 were considered to be statistically significant.
Analyses were performed using SPSS 15 (Lead Technologies).
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